Orphazyme A (ORPH) Return on Investment ROI from the fourth quarter of 2021 to fourth quarter of 2020 and for the year 2021, average high and low, overall ranking from Dec 31 2021 to Dec 31 2020 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Orphazyme A  (ORPH)


Orphazyme A's ROI from its fourth quarter of 2021 to the fourth quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Orphazyme A's ROI in the fourth quarter of 2021?
Orphazyme A recorded a cumulative net loss of $-100 million during 12 months ending in the fourth quarter of 2021, resulting in a negative return on investment (ROI) of -27.96%.

Within the Healthcare sector 907 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2021 from 0 to 4918.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2021)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2020)
IV. Quarter
Y / Y Investment Change TTM 111.89 % 11935.47 % - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 7 108 656 656 656
Return On Investment (TTM) -27.96 % -18.68 % -19.54 % -29.18 % -57.61 %
ORPH's Overall Ranking # 4918 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -31.28 % 4.56 % 49.35 % 97.44 % 3803.44 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -100 -97 -97 -97 -97

ORPH Company Profile >> Back to ORPH Roi Comparisons >> See Annual ORPH Return On Investment



Return On Investment ORPH's Ranking
Within: No.
Industry # 443
Sector # 908
Overall # 4918

Return On Investment Statistics
High Average Low
-95.53 %
-96.04 %
-96.55 %
(Dec 31 2021)   (Dec 31 2020)







Financial Statements
Orphazyme A's IV. Quarter Investments $ 7 Millions ORPH's Balance sheet
Orphazyme A's IV. Quarter Income $ -100 Millions Quarterly ORPH's Income Statement
ORPH's Income by Division See ORPH's Income by Division


ORPH Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020


Total Investments in Millions 44 656 0 0 0
Y / Y Investment Growth -93.27 % - - - -
Net Income in Millions -627 -633 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -1419.53 % -96.55 % - - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ORPH's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ORPH's Competitors
Subscribers only: Roi for Orphazyme A's Suppliers
Subscribers only: Return On Investment for ORPH's Customers

Other Ratios
ORPH's Roa ORPH's Inventory Turnover Ratio ORPH's Growth Rates ORPH's Dividend Statistics
ORPH's Profitability Ratios ORPH's Asset Turnover Ratio ORPH's Dividend Growth
ORPH's Roe ORPH's Valuation Ratios ORPH's Financial Strength Ratios ORPH's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2021, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.